What is Edwards Lifesciences's long-term debt?

Edwards Lifesciences (EW) reported long-term debt of $598.5M in Q1 2026.

How has Edwards Lifesciences's long-term debt changed year-over-year?

Edwards Lifesciences's long-term debt increased by 0.1% year-over-year, from $597.8M to $598.5M.

What is the long-term trend for Edwards Lifesciences's long-term debt?

Over 5 years (2020 to 2025), Edwards Lifesciences's long-term debt has grown at a 0.1% compound annual growth rate (CAGR), from $595M to $598.3M.

What does long-term debt mean?

Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

Edwards Lifesciences EW Long-Term Debt

Long-Term Debt at other companies

AbbottABT

$29.6B+129%

ArtivionAORT

$215.35M-31.5%

Merit Medical SystemsMMSI

$735.16M+0.6%

ICU MedicalICUI

$1.28B-16.6%

MedtronicMDT

$26.17B+2.1%

TFX

TeleflexTFX

$2.51B+39.1%

Other financials

Income statement

See full

Revenue$1.7B+13.6%

Gross profit$1.3B+13.5%

Operating income$513.2M+24.8%

Net income$241.9M-27.4%

EPS (diluted)$0.42-25.0%

Balance sheet

See full

Cash & equivalents$2.4B-22.3%

Total debt$702.9M+0.5%

Total equity$10.3B+2.0%

Total assets$13.3B+2.3%

Cash flow

See full

Operating cash flow$43.8M-84.4%

CapEx$64.9M+15.9%

Free cash flow-$21.1M-109%

Valuation

See full

Market cap$48.18B+3.7%

Enterprise value$46.44B+11.0%

P/E48×+36.7×

P/S7.4×-0.8×

Profitability

See full

Gross margin77.8%-1.0pp

Operating margin22.3%-3.6pp

Net margin15.4%-57.5pp

FCF margin17.3%—

Returns & leverage

See full

Return on equity10.7%-37.8pp

Debt / equity0.1×0.0×

Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Edwards Lifesciences's long-term debt?: Edwards Lifesciences (EW) reported long-term debt of $598.5M in Q1 2026.
How has Edwards Lifesciences's long-term debt changed year-over-year?: Edwards Lifesciences's long-term debt increased by 0.1% year-over-year, from $597.8M to $598.5M.
What is the long-term trend for Edwards Lifesciences's long-term debt?: Over 5 years (2020 to 2025), Edwards Lifesciences's long-term debt has grown at a 0.1% compound annual growth rate (CAGR), from $595M to $598.3M.
What does long-term debt mean?: Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.